The growth of injectable critical care therapeutics requires
multi-layer protection and authentication solutions.

As counterfeiting becomes a mounting concern, drug manufacturers are taking a proactive approach to the problem. Many companies are thinking more broadly about coordinated anti-counterfeiting, anti-diversion strategies across their brands and throughout different regions of the world.

Download this whitepaper to learn how they are implementing multi-layered solutions for drug protection.